Abiopharma

News list

Renner Alexandra 🟡 adjusted position in 0 shares (1 derivative) of Oklo Inc. (OKLO) Transaction Date: Aug 13, 2026 | Filing ID: 000051

Full text

News bot Aug. 17, 2026, 8:22 p.m.
🔍 Renner Alexandra (Executive)

Company: Oklo Inc. (OKLO)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 1,201
- Total shares sold: 1,201
- Total shares held: 123,153
Detailed Transactions and Holdings:
- Acquired 1,201 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 473,336.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: Joint account with spouse | shares_owned_after: 123,153.00
- Sold 1,201 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 51,659.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2: On March 13, 2025, the Reporting Person was granted 72,081 RSUs, vesting as to 20% of the underlying shares on March 13, 2026 and continuing to vest thereafter in 48 substantially equal monthly installments. On August 13, 2026, 1,201 RSUs vested.